Hepatic involvement in sarcoidosis

  • Authors: Fomin VV1, Brovko MY.2, Kalashnikov MV3, Sholomova VI2,3, Rozina TP2,4, Akulkina LA2, Pershina AE4, Yanakayeva AS.2, Nekrasova TP5
  • Affiliations:
    1. I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Faculty of Medicine, Department of Internal Medicine No.1
    2. I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), E.M. Tareev Clinic of Internal Diseases
    3. I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Medical and Preventive Faculty, Department of Internal, Occupational Diseases and Rheumatology
    4. M.V. Lomonosov Moscow State University, Faculty of Base Medicine, Department of Internal Medicine
    5. I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), A.I. Strukov Department of Pathological Anatomy
  • Issue: Vol 91, No 4 (2019)
  • Pages: 4-12
  • Section: Articles
  • URL: https://ter-arkhiv.ru/0040-3660/article/view/33560
  • DOI: https://doi.org/10.26442/00403660.2019.04.000179
  • Cite item

Abstract


Sarcoidosis is a multisystem granulomatous disease of unknown etiology. Liver is frequently involved in the pathological process. Wide range of clinical manifestations can be seen: from asymptomatic lesion with normal liver function tests to cirrhosis with portal hypertension. Biopsy plays the key role in diagnosis of the hepatic sarcoidosis. It is essential for morphological diagnosis to exclude other causes of granulomatous liver disease, most often - primary biliary cholangitis. Nowadays there are no standard treatment protocols for patients with hepatic sarcoidosis.

Full Text

Restricted Access

About the authors

V V Fomin

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Faculty of Medicine, Department of Internal Medicine No.1

M Yu Brovko

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), E.M. Tareev Clinic of Internal Diseases

M V Kalashnikov

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Medical and Preventive Faculty, Department of Internal, Occupational Diseases and Rheumatology

V I Sholomova

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), E.M. Tareev Clinic of Internal Diseases; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Medical and Preventive Faculty, Department of Internal, Occupational Diseases and Rheumatology

Email: vsholomova@mail.ru

T P Rozina

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), E.M. Tareev Clinic of Internal Diseases; M.V. Lomonosov Moscow State University, Faculty of Base Medicine, Department of Internal Medicine

L A Akulkina

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), E.M. Tareev Clinic of Internal Diseases

A E Pershina

M.V. Lomonosov Moscow State University, Faculty of Base Medicine, Department of Internal Medicine

A Sh Yanakayeva

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), E.M. Tareev Clinic of Internal Diseases

T P Nekrasova

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), A.I. Strukov Department of Pathological Anatomy

References

  1. Мухин Н.А., редактор. Саркоидоз. Клинические рекомендации. М.: ИМА-ПРЕСС; 2009: 54
  2. Kahi C.J, Saxena R, Temkit M. Hepatobiliary disease in sarcoidosis. Sarcoidosis Vasculitis Diffuse Lung Dis. 2006;23(2):117-23.
  3. Визель А.А., Амиров Н.Б. Саркоидоз и поражение органов системы пищеварения. Вестник современной клинической медицины. 2010;(1):43-50.
  4. Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet P.Y, Müller-Quernheim J. Sarcoidosis. Lancet. 2014;383(9923):1155-67. doi: 10.1016/S0140-6736(13)60680-7
  5. Hardman T, Sharma R, Dubrey S, Shah S. Sarcoidosis: the links between epidemiology and aetiology. Postgrad Med J. 2014;90(1068):582-9. doi: 10.1136/postgradmedj-2014-132584
  6. Dumas O, Abramovitz L, Wiley A.S, Cozier Y.C, Camargo C.A.Jr. Epidemiology of sarcoidosis in a prospective cohort study of U.S. women. Ann Am Thorac Soc. 2016;13(1):67-71. doi: 10.1513/AnnalsATS.201508-568BC
  7. Визель А.А., Визель И.Ю., Амиров Н.Б. Эпидемиология саркоидоза в Российской Федерации. Вестник современной клинической медицины. 2017;(5):66-73. doi: 10.20969/VSKM.2017.10(5).66-73
  8. Ramos-Casals M, Brito-Zerón P, Kostov B, Sisó-Almirall A, Bosch X, Buss D, Trilla A, Stone J.H, Khamashta M.A, Shoenfeld Y. Google - driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases. Autoimmun Rev. 2015;14(8):670-9. doi: 10.1016/j.autrev.2015.03.008
  9. Hillerdal G, Nöu E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis. 1984;130(1):29-32.
  10. Sawahata M, Sugiyama Y, Nakamura Y, Nakayama M, Mato N, Yamasawa H, Bando M. Age - related and historical changes in the clinical characteristics of sarcoidosis in Japan. Respir Med. 2015;109(2):272-8. doi: 10.1016/j.rmed.2014.12.012
  11. Holmes J, Lazarus A. Sarcoidosis: extrathoracic manifestations. Dis Mon. 2009;55:675-92. doi: 10.1016/j.disamonth.2009.05.002
  12. Baughman R, Baughman R.P, Teirstein A.S, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164:1885-9. doi: 10.1164/ajrccm.164.10.2104046
  13. Scadding J. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J. 1961;2(5261):1165-72.
  14. Терпигорев С.А., Эльзейн Б.А., Верещагина В.М. и др. Саркоидоз и проблемы его классификации. Вестник Российской медицинской академии наук. 2012;(5):30-7.
  15. Maddrey W.C, Johns C.J, Boitnott J.K, Iber F.L. Sarcoidosis and chronic hepatic disease: a clinical and pathologic study of 20 patients. Medicine (Baltimore). 1970;49(5):375-95. doi: 10.1097/00005792-197009000-00002
  16. Culver D. Sarcoidosis. Immunol Allergy Clin North Am. 2012;32(4):487-511. doi: 10.1016/j.iac.2012.08.005
  17. Zissel G, Prasse A, Müller-Quernheim J. Immunologic response of sarcoidosis. Semin Respir Crit Care Med. 2010;31(4):390-403. doi: 10.1055/s-0030-1262208
  18. Lazarus A. Sarcoidosis: epidemiology, etiology, pathogenesis, and genetics. Dis Mon. 2009;55(11):649-60. doi: 10.1016/j.disamonth.2009.04.008
  19. Chen E, Moller D. Etiology of sarcoidosis. Clin Chest Med. 2008;29(3):365-77. doi: 10.1007/s12016-015-8481-z
  20. Suzuki Y, Uchida K, Takemura T. Propionibacterium acnes - derived insoluble immune complexes in sinus macrophages of lymph nodes affected by sarcoidosis. PLoS One. 2018;13(2). Accessed Nov 5, 2018. doi: 10.1371/journal.pone.0192408
  21. Vihlborg P, Bryngelsson I.L, Andersson L, Graff P. Risk of sarcoidosis and seropositive rheumatoid arthritis from occupational silica exposure in Swedish iron foundries: a retrospective cohort study. BMJ Open. 2017;7:1-7. doi: 10.1136/bmjopen-2017-016839
  22. Лопаткина Т.Н., Пономарев А.Б., Попова Е.Н. и др. Интерферон - индуцированный (лекарственный) саркоидоз. Клиническая фармакология и терапия. 2008;(5):45-8.
  23. Alazemi S. Interferon - induced sarcoidosis. Int J ClinPract. 2006;60(2):201-11. doi: 10.1111/j.1742-1241.2005.00651.x
  24. Fiel M.I, Shukla D, Saraf N. Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantation. Transpl Infect Dis. 2008;10:184-9. doi: 10.1111/j.1399-3062.2007.00258.x
  25. Lamps L. Hepatic granulomas. A review with emphasis on infectious cause. Arch Pathol Lab Med. 2015;139:867-75. doi: 10.5858/arpa.2014-0123-RA
  26. Costabel U, Hunninghake G. ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J. 1999;14(4):735-7.
  27. Kennedy P, Zakaria N, Modawi S.B, Papadopoulou A.M, Murray-Lyon I, du Bois R.M, Jervoise N, Andreyev H, Devlin J. Natural history of hepatic sarcoidosis and its response to treatment. Eur J Gastroenterol Hepatol. 2006;18(7):721-6. doi: 10.1097/01.meg.0000223911.85739.38
  28. Modaresi E, Culver D, Plesec T, John B. Clinical presentation and protocol for management of hepatic sarcoidosis. Expert Rev Gastroenterol Hepatol. 2015;9(3):349-58. doi: 10.1586/17474124.2015.958468
  29. Drebber U, Drebber U, Kasper H.U, Ratering J, Wedemeyer I, Schirmacher P, Dienes H.P, Odenthal M. Hepatic granulomas: histological and molecular pathological approach to differential diagnosis - a study of 442 cases. Liver Int. 2008;28(6):828-34. doi: 10.1111/j.1478-3231.2008.01695.x
  30. Dourakis.SP, Saramadou R, Alexopoulou A. Hepatic granulomas: a 6-year experience in a single center in Greece. Eur J Gastroenterol Hepatol. 2007;19(2):101-4. doi: 10.1097/01.meg.0000243882.09820.d2
  31. Lewis J. Histopathology of granulomatous liver disease. Clin Liv Dis. 2018;11(3):77-80. doi: 10.1002/cld.695
  32. Yee A.M. Sarcoidosis: rheumatology perspective. Best Pract Res Clin Rheumatol. 2016;30(2):334-56. doi: 10.1016/j.berh.2016.07.001
  33. Tadros M, Forouhar F, Wu G. Hepatic sarcoidosis. J Clin Transl Hepatol. 2013;2:87-93. doi: 10.14218/JCTH.2013.00016
  34. Karagiannidis A, Karavalaki M, Koulaouzidis A. Hepatic sarcoidosis. Ann Hepatol. 2006;5(4):251-6.
  35. Лебедева М.В., Попова Е.Н., Пономарев А.Б. и др. Внелегочные проявления саркоидоза. Врач. 2011;(3):43-5.
  36. Dulai P.S, Rothstein R.I. Disseminated Sarcoidosis Presenting as Granulomatous Gastritis. A Clinical Review of the Gastrointestinal and Hepatic Manifestations of Sarcoidosis. J Clin Gastroenterol. 2012;46(5):367-74. doi: 10.1097/MCG.0b013e318247106b
  37. Mueller S. Extrapulmonary sarcoidosis primarily diagnosed in the liver. Scand J Gastroenterol. 2000;35:1003-8. doi: 10.3748/wjg.v13.i17.2504
  38. Greenwood R. Atypical Presentation of Hepatic Sarcoidosis. Hawaii J Med Public Health. 2013;72(9):55.
  39. Farooq P.D, Potosky D.R. The Klatskin Tumor That Wasn’t: An Unusual Presentation of Sarcoidosis. ACG Case Rep J. 2016;3(4):1-4. doi: 10.14309/crj.2016.114
  40. Gaduputieti V. Extrahepatic Biliary Obstruction: An Unusual Presentation of Hepatic Sarcoidosis. Clin Med Insights Gastroenterol. 2015;8:19-22. doi: 10.4137/CGast.S22809
  41. Rezeig M.A, Fashir B.M. Biliary tract obstruction due to sarcoidosis: a case report. Am J Gastroenterol. 1997;92(3):527-8.
  42. Suzuki I, Zenichi M, Shinpei F, Yoshinao T, Chinatsu T, Tadashi K, Masahiro I, Atsushi S. Hepatic Sarcoidosis Mimicking Hilar Cholangiocarcinoma: Case Report and Review of the Literature. Case Rep Gastroenterol. 2011;5(1):152-8. doi: 10.1159/000323546
  43. Menias C.O, Surabhi V.R, Prasad S.R, Wang H.L, Narra V.R, Chintapalli K.N. Mimics of Cholangiocarcinoma: Spectrum of Disease. RadioGraphics. 2008;28(4):1115-29. doi: 10.1148/rg.284075148
  44. Philips C.A, Kalal C.R, Kumar A. Sarcoidosis Presenting as Acute on Chronic Liver Failure - Report of the First Case. Med Sci. 2016;5(2):655-65. doi: 10.5455/medscience.2015.04.8325
  45. Judson M, Baughman R.P, Costabel U, Flavin S, Lo K.H, Kavuru M.S, Drent M. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J. 2008;31(6):1189-96. doi: 10.1183/09031936.00051907
  46. Ayyala U, Padilla M. Diagnosis and treatment of hepatic sarcoidosis. Curr Treat Options Gastroenterol. 2006;9(6):475-83.
  47. Cremers J, Drent M, Baughman R.P, Wijnen P.A, Koek G.H. Therapeutic approach of hepatic sarcoidosis. Curr Opin Pulm Med. 2012;18(5):472-87. doi: 10.1097/MCP.0b013e3283541626
  48. Syed U, Alkhawam H, Bakhit M, Ching Companioni R, Walfish A. Hepatic sarcoidosis: pathogenesis, clinical context, and treatment options. Scand J Gastroenterol. 2016;51(9):1025-30. doi: 10.1080/00365521.2016.1177856
  49. Baughman R. Sarcoidosis usual and unusual manifestations. Chest. 1988;94:165-70.
  50. Sharma O.P. Vitamin D, calcium, and sarcoidosis. Chest. 1996;109:535-9.
  51. Inui N, Murayama A. Correlation between 25-hydroxyvitamin D3 1-alpha - hydroxylase gene expression in alveolar macrophages and the activity of sarcoidosis. Am J Med. 2001;110:687-93.
  52. Ackermann D. Hypercalcemia in sarcoidosis - case report, prevalence, pathophysiology and therapeutic options. Ther Umsch. 2007;64:281-6. doi: 10.1024/0040-5930.64.5.281
  53. Yanardag H, Pehlivan M, Bilir M, Tetikkurt C. Clinical Features and Prognostic Significance of Liver Involvement in Sarcoidosis. Eur Respir Pulmon Dis. 2016;2(1):26-9. doi: 10.4081/monaldi.2017.893
  54. Kessler A, Mitchell D, Israel H, Goldberg B. Hepatic and splenic sarcoidosis: ultrasound and MR imaging. Abdom Imaging. 1993;18(2):159-63.
  55. Ebert E, Kierson M, Hagspiel K. Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol. 2008;103(12):3184-92. doi: 10.1111/j.1572-0241.2008.02202.x
  56. Gezer N, Başara I, Altay C, Harman M, Rocher L, Karabulut N, Seçil M. Abdominal sarcoidosis: cross - sectional imaging findings. Diagn Interv Radiol. 2015;21(2):111-7. doi: 10.5152/dir.2014.14210
  57. Karaosmanoğlu A, Onur M.R, Saini S, Taberi A, Karcaaltincaba M. Imaging of hepatobiliary involvement in sarcoidosis. Abdom Imaging. 2015;40(8):3330-7. doi: 10.1007/s00261-015-0533-6
  58. Tana C, Dietrich C, Schiavone C. Hepatosplenic sarcoidosis: contrast - enhanced ultrasound findings and implications for clinical practice [WEB resousce]. Biomed Res Int. 2014:926203. Accessed November 5, 2018. https://www.hindawi.com/journals/bmri/2014/926203/. doi: 10.1155/2014/926203
  59. Grzelak P. Diagnostic potential of contrast - enhanced ultrasound (CEUS) in the assessment of spleen and liver granulomas in the course of sarcoidosis. Pneumonol Alergol Pol. 2013;81(5):424-8.
  60. Naschitz J, Enat R, Yeshurun D, Eisenberg D, Baruch Y, Bassan L, Misselevitch I, Boss J.H. Massive subcapsular fibrosis of the liver: ultrasonic and computed tomographic characteristics. J Clin Gastroenterol. 1991;13(2):470-4.
  61. Ferreira A, Ramalho M, de Campos R.O, Heredia V, Roque A, Vaidean G, Semelka R.C. Hepatic sarcoidosis: MR appearances in patients with chronic liver disease. Magn Reson Imaging. 2013;31(3):432-8. doi: 10.1016/j.mri.2012.08.005
  62. Jung G, Brill N, Poll L.W, Koch J.A, Wettstein M. MRI of hepatic sarcoidosis: large confluent lesions mimicking malignancy. AJR Am J Roentgenol. 2004;183(1):171-3. doi: 10.2214/ajr.183.1.1830171
  63. Warshauer D, Dumbleton S.A, Molina P.L, Yankaskas B.C, Parker L.A, Woosley J.T. Abdominal CT findings in sarcoidosis: radiologic and clinical correlation. Radiology. 1994;192(1):93-8. doi: 10.1148/radiology.192.1.8208972
  64. Saito H, Ohmori M, Iwamuro M, Tanaka T, Wada N, Yasunaka T, Takaki A. Hepatic and gastric involvement in a case of systemic sarcoidosis presenting with rupture of esophageal varices. Intern Med. 2017;56(19):2583-8. doi: 10.2169/internalmedicine.8768-16
  65. Heinle R, Chang C. Diagnostic criteria for sarcoidosis. Autoimmun Rev. 2014;13(5):383-7. doi: 10.1016/j.autrev.2014.01.035
  66. Stanca C.M, Fiel M.I, Allina J, Caracta C.F, Odin J.A. Liver failure in an antimitochondrial antibody - positive patient with sarcoidosis: primary biliary cirrhosis or hepatic sarcoidosis? Semin Liver Dis. 2005;25:364-70. doi: 10.1055/s-2005-916327
  67. Gur C, Lalazar G, Doviner V, Lalazar G, Doviner V, Fridlender Z.G, Molcho V, Abu-Much S, Shalit M, Elinav E. Late - onset sarcoidosis after liver transplantation for primary biliary cirrhosis. J Clin Gastroenterol. 2007;41:329-32. doi: 10.1097/01.mcg.0000212653.51397.f6
  68. Kishor Turner M.L, Borg B.B, Kleiner D.E, Cowen E.W. Cutaneous sarcoidosis and primary biliary cirrhosis: A chance association or related diseases? J Am Acad Dermatol. 2007;38(2):326-35. doi: 10.1016/j.jaad.2007.07.031
  69. Koulentaki M, Ioannidou D, Stefanidou M, Maraki S, Drigiannakis I, Dimoulios P. Dermatological manifestations in primary biliary cirrhosis patients: a case control study. Am J Gastroenterol. 2006;101:541-6. doi: 10.1111/j.1572-0241.2006.00423.x
  70. Sherman S, Nieland N, van Thiel D. Sarcoidosis and primary biliary cirrhosis: coexistence in a single patient. Dig Dis Sci. 1988;33:368-74.
  71. Leff J.A, Ready J.B, Repetto C, Goff J.S, Schwarz M. Coexistence of primary biliary cirrhosis and sarcoidosis. West J Med. 1990;153:439-41.
  72. Asvesti C, Hadziyannis SJ, Papadopoulos S, Giakoumoglou T, Hadziolou E, Trichia E. Sweat gland carcinoma in a patient with sarcoidosis and primary biliary cirrhosis. Dermatology. 1994;189:198-202.
  73. Keefe E.B. Sarcoidosis and primary biliary cirrhosis: literature review and illustrative case. Am J Med. 1987;83:977-80.
  74. Harrington A.C, Fitzpatrick J.E. Cutaneous sarcoidal granulomas in a patient with primary biliary cirrhosis. Cutis. 1992;49:271-4.
  75. Jardine D.L, Chambers S.T, Hart D.J, Chapman B.A. Primary biliary cirrhosis presenting with granulomatous skin lesions. Gut. 1994;35:564-6.
  76. Hughes P, Mc Gavin C.R. Sarcoidosis and primary biliary cirrhosis with coexisting myositis. Thorax. 1997;52:201-2.
  77. Попова Е.Н., Некрасова Т.П., Танащук Е.Л. и др. Вариантная форма аутоиммунного гепатита/первичного билиарного цирроза в сочетании с генерализованным саркоидозом. Доказательная гастроэнтерология. 2017;(3):51-9.
  78. Al-Kofahi K, Korsten P, Ascoli C, Virupannavar S, Mirsaeidi M, Chang I, Qaqish N, Saketkoo L.A, Baughman R.P, Sweiss N.J. Management of extrapulmonary sarcoidosis: challenges and solutions. Ther Clin Risk Manag. 2016;12:1623-34. doi: 10.2147/TCRM.S74476
  79. Bakker G, Haan Y, Maillette de Buy Wenniger L, Beuers U. Sarcoidosis of the liver: to treat or not to treat? Neth J Med. 2012;70(8):349-56.
  80. Cremers J, Drent M, Driessen A, Nieman F, Wijnen P, Baughman R, Koek G. Liver - test abnormalities in sarcoidosis. Eur J Gastroenterol Hepatol. 2012;24(1):17-24. doi: 10.1097/MEG.0b013e32834c7b71
  81. Alenezi B, Lamoureux E, Alpert L, Szilagyi A. Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis. Dig Dis Sci. 2005;50(1):196-200.
  82. Baratta L, Cascino A, Delfino M, Giorgino F, Vitolo D, Laganà B, Urani C, Rossi Fanelli F. Ursodeoxycholic acid treatment in abdominal sarcoidosis. Dig Dis Sci. 2000;45(8):1559-62.
  83. Baughman R, Lynch J. Difficult treatment issues in sarcoidosis. J Intern Med. 2003;253(1):41-5.
  84. Bécheur H, Dall'osto H, Chatellier G, Charton-Bain M.C, Aubertin J.M, Attar A, Bloch F, Petite J.P. Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis. Dig Dis Sci. 1997;42(4):789-91.
  85. Heuman D. Hepatoprotective properties of ursodeoxycholic acid. Gastroenterology. 1993;104(6):1865-70.
  86. Wan Y. TPMT testing before azathioprine therapy? Drug Ther Bull. 2009;47(1):9-12. doi: 10.1136/dtb.2008.12.0033
  87. Ulbricht K, Stoll M, Bierwirth J, Witte T, Schmidt R.E. Successful tumor necrosis factor alpha blockade treatment in therapy - resistant sarcoidosis. Arthritis Rheum. 2003;48(12):3542-3. doi: 10.1002/art.11357
  88. Doty J, Mazur J, Judson M. Treatment of sarcoidosis with infliximab. Chest. 2005;127(3):1064-71. doi: 10.1378/chest.127.3.1064
  89. Saleh S, Ghodsian S, Yakimova V, Henderson J, Sharma O.P. Effectiveness of infliximab in treating selected patients with sarcoidosis. Respir Med. 2006;100(11):2053-9. doi: 10.1016/j.rmed.2006.02.017
  90. Denys B, Bogaerts Y, Coenegrachts K, De Vriese A. Steroid - resistant sarcoidosis: is antagonism of TNF-alpha the answer? Clin Sci (Lond). 2007;112(5):281-9. doi: 10.1042/CS20060094
  91. Costabel U. Sarcoidosis: clinical update. Eur Respir J Suppl. 2001;32:56-68.
  92. Cengiz C, Rodriguez-Davalos M, de Boccardo G, Fiel M.I, Rodriguez-Laiz G, Kovacevic M, Emre S, Schiano T. Recurrent hepatic sarcoidosis post - liver transplantation manifesting with severe hypercalcemia: a case report and review of the literature. Liver Transpl. 2005;11(12):1611-4. doi: 10.1002/lt.20626
  93. Bilal M, Satapathy S, Ismail M, Vanatta J. Long-Term Outcomes of Liver Transplantation for Hepatic Sarcoidosis: A Single Center Experience. J Clin Exp Hepatol. 2016;6(2):94-9. doi: 10.1016/j.jceh.2016.02.005
  94. Lipson E, Fiel M, Florman S, Korenblat K. Patient and graft outcomes following liver transplantation for sarcoidosis. Clin Transplant. 2005;19(4):487-91. doi: 10.1111/j.1399-0012.2005.00372.x
  95. Casavilla F, Gordon R, Wright H. Clinical course after liver transplantation in patients with sarcoidosis. Ann Intern Med. 1993;118(11):865-66.

Statistics

Views

Abstract - 31

PDF (Russian) - 9

Cited-By


PlumX

Dimensions

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:

 

© 2018 "Consilium Medicum" Publishing house

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies